Anqi Yin

机构：Harbin Medical University, Second Affiliated Hospital of Harbin Medical University, Huazhong University of Science and Technology · ORCID：0000-0002-3644-1460

发表论文 39 篇 · 总被引 812 次 · h-index 16

代表论文

• Tiragolumab in combination with atezolizumab and bevacizumab in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (MORPHEUS-Liver): a randomised, open-label, phase 1b–2, study (2025 · The Lancet Oncology · 被引 67)
• Results from the MORPHEUS-liver study: Phase Ib/II randomized evaluation of tiragolumab (tira) in combination with atezolizumab (atezo) and bevacizumab (bev) in patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (uHCC). (2023 · Journal of Clinical Oncology · 被引 51)
• DNA Holliday Junction: History, Regulation and Bioactivity (2022 · International Journal of Molecular Sciences · 被引 42)
• Gut metagenomic characteristics of ADHD reveal low Bacteroides ovatus -associated host cognitive impairment (2022 · Gut Microbes · 被引 41)
• Autophagy: A New Mechanism for Esketamine as a Depression Therapeutic (2022 · Neuroscience · 被引 37)
• Activation of astroglial CB1R mediates cerebral ischemic tolerance induced by electroacupuncture (2021 · Journal of Cerebral Blood Flow & Metabolism · 被引 36)